MR Contrast Agent Safety in the Age of Nephrogenic Systemic Fibrosis: Update 2014

Abstract

Nephrogenic systemic fibrosis (NFS) is a potentially fatal disease that is linked to the administration of gadolinium based contrast agents (GBCA). As the associated risk factors have been identified and countermeasures taken, NSF has become a rarity. However, there is ongoing research to better understand its pathogenesis and studies on the safety of different GBCA in the context of NSF are carried on. This article aims to provide a brief review of the topic of NSF and to summarize recent developments and literature publications within the last year.